UROTHELIAL CARCINOMA RECURRENT
Clinical trials for UROTHELIAL CARCINOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CARCINOMA RECURRENT trials appear
Sign up with your email to follow new studies for UROTHELIAL CARCINOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bladder cancer drug shows early promise in small trial
Disease control CompletedThis early-phase trial tested a new drug called UGN-301 (zalifrelimab) given directly into the bladder for people with recurrent non-muscle invasive bladder cancer. The study included 51 participants and aimed to check safety and find the right dose, both alone and with other dru…
Matched conditions: UROTHELIAL CARCINOMA RECURRENT
Phase: PHASE1 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a pill shrink bladder tumors before surgery?
Disease control CompletedThis phase 2 trial tested pemigatinib, a daily pill that blocks certain growth signals, in 30 people with recurrent low- or intermediate-risk non-muscle invasive bladder cancer. Participants took the drug for 4-6 weeks before their standard surgery to remove bladder tumors. The m…
Matched conditions: UROTHELIAL CARCINOMA RECURRENT
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC